Beryl Drugs Ltd

Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. To consider and approve the date of holding EOGM for regularising the appointment of Mr. Shailendra Pathak as the Whole Time Director of the Company and fixing his role obligations and responsibilities and remuneration and for the appointment of Mrs. Neha Sarda as an Independent Director and for approval for material Related Party Transactions with M/s. Aminova Infusions P. Ltd. where Mr. Shailendra Pathak is a director holding 50% equity.2. To consider and approve the Unaudited Quarterly Financial Results for the quarter ended 31st December 20253. To take on record the Limited Review Report by the Auditors for the quarter ended 31st December 2025